Could a depression drug help fight opioid addiction?

NCT ID NCT05976646

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase study tested whether adding a medication called Auvelity (a combination of dextromethorphan and bupropion) to standard buprenorphine treatment is safe and might help reduce cravings, withdrawal, and negative feelings in people with opioid use disorder. 18 adults on stable buprenorphine therapy took part. The main focus was on safety, like heart rate and side effects, while also looking for early signs that the combination could improve treatment outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior, Addictive opiate dependence opioid abuse substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CARI Research Clinic- VCU Institute for Drug and Alcohol Studies

    Richmond, Virginia, 23219, United States